🇺🇸 FDA
Patent

US 11795457

Compositions and methods for treatment of Friedreich's Ataxia

granted A61KA61K45/06A61P

Quick answer

US patent 11795457 (Compositions and methods for treatment of Friedreich's Ataxia) held by The Board of Regents of the University of Texas System expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K45/06, A61P, A61P25/00